Stocks · Healthcare · Medical - Instruments & Supplies
LeMaitre Vascular, Inc. LMAT
$78.96 -1.53% Close, Oct 2, 2026 · NASDAQ · Market cap $1.80B
High qualityInexpensive vs sector
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- At 27.7× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Diluted EPS over the last four quarters was $2.85, up 38.3% year over year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 44%
- EPS growth (TTM, YoY)Top 31%
- FCF growth (TTM, YoY)Top 32%
- Revenue growth, 3-year CAGRTop 38%
- Revenue growth accelerationBottom 38%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 15%
- Gross marginTop 39%
- Operating marginTop 7%
- Cash conversion (OCF / net income)Bottom 33%
- Accruals (lower is better)Bottom 28%
- Net debt / EBITDA (lower is better)Bottom 44%
- Interest coverTop 12%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 16%
- Free-cash-flow yieldTop 22%
- EBITDA / enterprise valueTop 23%
- Sales / enterprise valueBottom 37%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 33%
- 6-month returnBottom 18%
- 1-year return vs S&P 500Bottom 36%
- Distance from 52-week highBottom 49%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 45%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 39%
- Upside to consensus price targetBottom 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 35%
- Maximum drawdown, 3 yearsTop 6%
- Beta vs S&P 500 (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Bottom 44%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 13.3% | 11.8% | ↓ |
| EPS growth (YoY) | 36.9% | 38.3% | ↑ |
| Gross margin | 69.1% | 72.9% | ↑ |
| Operating margin | 23.3% | 29.5% | ↑ |
| FCF margin | 22.3% | 28.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 11.8% | 13.3% | ↓ | Top 44% |
| EPS growth (TTM, YoY) | 38.3% | 36.9% | ↑ | Top 31% |
| Gross margin | 72.9% | 69.1% | ↑ | Top 39% |
| Operating margin | 29.5% | 23.3% | ↑ | Top 7% |
| Net margin | 25.0% | 20.1% | ↑ | — |
| Free-cash-flow margin | 28.1% | 22.3% | ↑ | — |
| Return on invested capital | 9.8% | — | Top 15% | |
| Revenue growth, 3-year CAGR | 15.6% | — | Top 38% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.26×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -14.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.68×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 14.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.14%
- Net buyback yield (TTM)
- -0.38%
- Shareholder yield
- 0.75%
- Share count change, 1 year
- +7.2%
- Share count change, 3-year CAGR
- +3.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +1.5%
- Average 2-day reaction, last 8
- -0.1%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $115.00
- Target vs current price
- +45.6%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 70%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -8.3% | +2.1% | -21.6% | -22.5% | — |
| May 5, 2026 | +3.0% | +0.4% | -8.9% | -17.9% | -8.4% |
| Feb 25, 2026 | +1.5% | +0.7% | +18.8% | +21.2% | +11.8% |
| Nov 6, 2025 | +9.9% | -0.8% | +4.3% | -0.7% | +1.4% |
| Aug 5, 2025 | +5.3% | +1.5% | +9.8% | +12.6% | +6.1% |
| May 1, 2025 | -4.0% | -0.6% | -10.1% | -10.7% | -9.1% |
| Feb 27, 2025 | +0.0% | -3.0% | -15.6% | -18.0% | -23.2% |
| Oct 31, 2024 | +11.4% | -0.7% | +14.2% | +18.8% | +12.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.74 | $0.81 | -8.3% | $70.4M |
| May 5, 2026 | $0.68 | $0.66 | +3.0% | $66.6M |
| Feb 25, 2026 | $0.68 | $0.67 | +1.5% | $64.5M |
| Nov 6, 2025 | $0.62 | $0.56 | +9.9% | $61.0M |
| Aug 5, 2025 | $0.60 | $0.57 | +5.3% | $64.2M |
| May 1, 2025 | $0.48 | $0.50 | -4.0% | $59.9M |
| Feb 27, 2025 | $0.49 | $0.49 | +0.0% | $55.7M |
| Oct 31, 2024 | $0.49 | $0.44 | +11.4% | $54.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 27.7× | 45.3× | 0th | Top 16% |
| P/E (forward) | 27.5× | — | — | — |
| EV / EBITDA | 20.2× | — | — | Top 23% |
| EV / Sales | 7.50× | — | — | Bottom 37% |
| Free-cash-flow yield | 4.09% | — | — | Top 22% |
| Earnings yield | 3.61% | — | — | Top 16% |
P/E over the past five years
Range 27.7× – 70.4× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -8.9%
- Earnings per share growth (TTM)
- +38.3%
- Change in P/E multiple
- -38.8%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.5%
- 200-day average slope (20 days)
- -0.4%
- Distance from 50-day average
- -6.2%
- Distance from 200-day average
- -16.5%
- RSI (14)
- 39.5
- Relative volume
- 1.24×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 64.7%
- Volatility vs own 5-year history
- 97th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.50
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- -32.7%
- Maximum drawdown, 3 years
- -32.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 25, 2021 | May 9, 2022 | -38.3% | 219 days | 248 days (May 4, 2023) |
| Jun 23, 2023 | Oct 26, 2023 | -33.5% | 87 days | 84 days (Feb 28, 2024) |
| Apr 14, 2026 | Sep 10, 2026 | -32.9% | 103 days | Not yet recovered |
| Nov 22, 2024 | Apr 8, 2025 | -27.9% | 91 days | 222 days (Feb 26, 2026) |
| Nov 25, 2020 | Dec 14, 2020 | -16.4% | 12 days | 14 days (Jan 5, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.80B
- P/E (TTM)
- 27.7
- EPS, diluted (TTM)
- $2.85
- Revenue (TTM)
- $262.4M
- Dividend yield
- 1.20%
- 52-week range
- $78.22 – $118.01
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $154.4M | $161.7M | $193.5M | $219.9M | $249.6M |
| Gross profit | $101.4M | $104.9M | $127.0M | $150.9M | $178.5M |
| Operating income | $36.4M | $26.8M | $36.7M | $52.3M | $67.9M |
| Net income | $26.9M | $20.6M | $30.1M | $44.0M | $57.7M |
| EPS (diluted) | $1.25 | $0.93 | $1.34 | $1.93 | $2.52 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.8M | $55.7M | $59.9M | $64.2M | $61.0M | $64.5M | $66.6M | $70.4M |
| Net income | $11.1M | $11.2M | $11.0M | $13.8M | $17.4M | $15.6M | $15.7M | $17.1M |
| EPS (diluted) | $0.49 | $0.49 | $0.48 | $0.60 | $0.75 | $0.68 | $0.68 | $0.74 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $35.1M | $25.4M | $36.8M | $44.1M | $81.3M |
| Capital expenditure | -$4.9M | -$3.2M | -$7.3M | -$7.0M | -$6.8M |
| Free cash flow | $30.2M | $22.1M | $29.5M | $37.2M | $74.5M |
| Dividends paid | -$9.3M | -$11.0M | -$12.4M | -$14.4M | -$18.1M |
| Net share buybacks | $63.2M | $3.5M | $6.2M | $6.4M | $6.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $376.2M
- Total assets
- $640.5M
- Total liabilities
- $220.2M
- Total debt
- $190.3M
- Net debt
- $163.6M
- Shareholders’ equity
- $420.3M
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 20, 2026 | $0.25 | Sep 3, 2026 |
| May 21, 2026 | $0.25 | Jun 4, 2026 |
| Mar 12, 2026 | $0.25 | Mar 26, 2026 |
| Nov 20, 2025 | $0.20 | Dec 4, 2025 |
| Aug 21, 2025 | $0.20 | Sep 4, 2025 |
| May 15, 2025 | $0.20 | May 29, 2025 |
| Mar 13, 2025 | $0.20 | Mar 27, 2025 |
| Nov 21, 2024 | $0.16 | Dec 5, 2024 |
Short interest
- Shares sold short
- 1,693,134
- Days to cover
- 6.31
- Change vs previous report
- +11.3%
FINRA short interest, settlement date Sep 15, 2026.